Amy GilesIncreasing Engagement
Bud BilanichSuccess Coach
Frank BurrellScientific Storytelling
Suma Ramadas, PhDMedical Affairs
Joey CohenMedication Adherence
Liz KaneImpactful Strategy
Pat PurcellMeeting Engagement
Brenda SnowAuthentic Patient Voice
David LinetskyPoint-of-Care Marketing
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Matt TurnerPatient Affordability
Matthew DurhamOmnidynamic Marketing
Paul TheisenPatient Acquisition
YELIVA®, a proprietary, first-in-class SK2 inhibitor, was granted FDA Orphan Drug designation for the ...
MEDFORD, N.Y., Dec. 20, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in ...
Company reported net ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) sales of $7.0 million in ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email